Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 1/20 | 0.42 |
| ▸ | RPA1 | P27694 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 12/20 | 0.40 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.40 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6415096 | 0.94 | AURKA (0.38) | BIRC5RPA1ALDH1A1POLBMAPT | |
| SCHEMBL6419747 | 0.93 | BIRC5 (0.43) | BIRC5RPA1ALDH1A1KDM4EPOLB | |
| SCHEMBL6414872 | 0.91 | RPA1 (0.43) | RPA1CSNK2A1CSNK2A2CSNK2BALDH1A1 | |
| SCHEMBL6431830 | 0.90 | BIRC5 (0.44) | BIRC5CSNK2A1CSNK2A2CSNK2BALDH1A1 | |
| SCHEMBL6434895 | 0.90 | BIRC5 (0.45) | BIRC5CSNK2A1ALDH1A1KDM4EPOLB | |
| SCHEMBL6432253 | 0.88 | RPA1 (0.44) | RPA1CSNK2A1CSNK2A2CSNK2BALDH1A1 | |
| SCHEMBL6415701 | 0.88 | CSNK2A1 (0.45) | CSNK2A1CSNK2A2CSNK2BPOLBMAPT | |
| SCHEMBL6415683 | 0.88 | CSNK2A1 (0.45) | CSNK2A1CSNK2A2CSNK2BPOLBMAPT | |
| SCHEMBL6413428 | 0.88 | BIRC5 (0.47) | BIRC5CSNK2A1CSNK2A2CSNK2BALDH1A1 | |
| SCHEMBL6416017 | 0.86 | KDR (0.38) | BIRC5RPA1ALDH1A1KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143382-A1 | Heterocyclic compounds as pharmaceutically active compounds | 4SC AG (DE) | 2005-06-30 | — | — | US | disclosed |
| EP-1529531-A1 | Oxadiazolopyrazine derivatives as pharmaceutically active compounds | 4SC AG (DE) | 2005-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143382-A1 | Heterocyclic compounds as pharmaceutically active compounds | NR5A2, NR1H2, NR2C2 | BIRC5 2525/4885RPA1 3166/4885CSNK2A1 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.